Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T20:25:15.162Z Has data issue: false hasContentIssue false

Optimisation of time-scheduled regimenfor anti-cancer drug infusion

Published online by Cambridge University Press:  15 November 2005

Claude Basdevant
Affiliation:
Université Paris-Nord, Villetaneuse and École Normale Supérieure, 75005 Paris, France. basdevant@lmd.ens.fr
Jean Clairambault
Affiliation:
INRIA, projet BANG, 78153 Rocquencourt, France. jean.clairambault@inria.fr (corresponding author)
Francis Lévi
Affiliation:
INSERM E 0354, Hôpital Paul-Brousse, 94800 Villejuif, France. levi-f@vjf.inserm.fr
Get access

Abstract

The chronotherapy concept takes advantage of the circadian rhythm of cells physiology in maximising a treatment efficacy on its target while minimising its toxicity on healthy organs. The object of the present paper is to investigate mathematically and numerically optimal strategies in cancer chronotherapy. To this end a mathematical model describing the time evolution of efficiency and toxicity of an oxaliplatin anti-tumour treatment has been derived. We then applied an optimal control technique to search for the best drug infusion laws.The mathematical model is a set of six coupled differentialequations governing the time evolution of both the tumour cell population(cells of Glasgow osteosarcoma, a mouse tumour) and the mature jejunalenterocyte population, to be shielded from unwanted side effectsduring a treatment by oxaliplatin. Starting from known tumour and villi populations, and a time dependent freeplatinum Pt (the active drug) infusion law being given,the mathematical model allows to compute the time evolution of both tumour andvilli populations. The tumour population growth is based on Gompertz law and the Pt anti-tumour efficacy takes into account the circadian rhythm. Similarly the enterocyte population is subject to a circadian toxicityrhythm. The model has been derived using, as far as possible, experimental data.We examine two different optimisation problems. The eradication problem consists in finding the drug infusion law able to minimise the number of tumour cells while preserving a minimal level for the villi population. On the other hand, the containment problem searches for a quasi periodic treatment able to maintain the tumour population at the lowest possible level, while preserving the villi cells. The originality of these approaches is that the objective and constraint functions we use are L ∞ criteria. We are able to derive their gradients with respect to the infusion rate and then to implement efficient optimisation algorithms.

Information

Type
Research Article
Copyright
© EDP Sciences, SMAI, 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable